Follow CGSP on Social Media

Listen to the CGSP Podcast

As Infections Rise in Countries Previously Vaccinated With Chinese Jabs, Doubts Persist About Vaccine Efficacy

A medical personel injects the first dose of the Chinese Covid-19 vaccine produced by Sinopharm at the Seychelles Hospital in Victoria, on January 10, 2021. Rassin VANNIER / AFP

The effectiveness of Chinese-made vaccines is emerging as an enduring narrative in the U.S. media due in part to resurgent infection rates in countries that have relied heavily on Sinopharm and Sinovac jabs.

But a lot of this coverage lacks nuance and is simply associating the higher infection rate with the presence of Chinese vaccines without delving into detail about which segments of the population are becoming infected and why. For example, the majority of new infections in countries like the Seychelles are from people who are either unvaccinated or became infected prior to the two-week period it takes for the the vaccines to take full effect.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.